Prevention of Postoperative Nausea and Vomiting with Granisetron and Dolasetron in Relation to CYP2D6 Genotype-Reference-Cited by-同舟云学术

Prevention of Postoperative Nausea and Vomiting with Granisetron and Dolasetron in Relation to CYP2D6 Genotype

Published:2006-04 Issue:4 Volume:102 Page:1127-1133
ISSN:0003-2999
Container-title:Anesthesia & Analgesia
language:en
Short-container-title:

Author:

Janicki Piotr K.,Schuler H Gregg,Jarzembowski Tomasz M.,Rossi Malina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference26 articles.

1. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?;Gan;CNS Drugs,2005

2. 5-HT3-receptor antagonists and the cytochrome P450 system: clinical implications.;Blower;Cancer J,2002

3. Granisetron: an update on its clinical use in the management of nausea and vomiting.;Aapro;Oncologist,2004

4. A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.;Audhuy;Eur J Cancer,1996

5. Patient outcomes after therapeutic interchange of dolasetron for granisetron.;Steiner;Am J Health Syst Pharm,2003

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-Wide Association Study Identifies Novel Candidate Variants Associated with Postoperative Nausea and Vomiting;Cancers;2023-09-26

2. The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics;Minerva Anestesiologica;2023-06

3. Perioperative Precision Medicine and Bedside Decision Making: Still a Case of Great Expectations?;Anesthesia & Analgesia;2022-04-05

4. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis;Cochrane Database of Systematic Reviews;2020-10-19

CHRM3 rs2165870 Polymorphism Correlates with Postoperative Nausea and Vomiting Incidence and the Efficacy of Ondansetron in a Chinese Han Population

;Pharmacogenomics and Personalized Medicine;2020-08